SEC Form 4 · accession 0001493152-16-009420
KIWA BIO-TECH PRODUCTS GROUP CORP · KWBT.OB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yvonne Wang
Officer — Chief Executive Officer
Period of report
Apr 1, 2016
Accepted (ET)
May 4, 2016 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159275
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2016 | J | 240,000 | $1.00 | A | 240,000 | D | |
| Series A Preferred Stock | Dec 9, 2015 | J | 250,000 | $100.00 | A | 250,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF3 | $0.175 | Dec 12, 2006 | A | 626 | A | Dec 12, 2006 | Dec 4, 2016 | Common Stock | 626 | 626 | D |
Explanation of responses
- F1Conversion of $240,000 Convertible Debt at $1.00 per share
- F2Conversion of $500,000 Convertible Debt at $2.00 per share
- F3Adjusted for a 1 for 200 reverse stock split effective January 28, 2016